Ketamine IV for the prevention of depression in the elderly: new data

Published Date: 13 Mar 2023

Intravenous (IV) ketamine is effective in adults resistant to depression. The response was similar to that seen in younger patients, two new studies show.

Read Full News

Latest News

Could Red Light Help Tackle Resistant Klebsiella Pneumoniae?

Researchers report that photodynamic therapy increases antibiotic penetration and disrupts resistance mechanisms in laboratory strains.

Gut Infection Disease Care: From GP Clinics to Hospitals

An infectious intestinal disease episode can be noted in both primary care and hospital admissions, with children and older adults having higher odds of admissions during a primary care episode.

Booster Shots Reduce Risk for Severe COVID Outcomes

According to a study of more than 5.5 million adults aged 50 years or older, vaccination with the bivalent BA.1 mRNA booster lowers risks for COVID-related hospitalisation and death.

Unmarried Older Adults Face Increased Humerus Fracture Risk

Older adults of Norwegian origin and those who are unmarried face an increased risk for humerus fractures, with a higher incidence seen in winter than in summer and more injuries occurring outdoors.

NHS Boosts Bone Scanning With 20 New DEXA Units

Twenty new DEXA scanners will expand NHS capacity in England, aiming to speed diagnosis and reduce fragility fractures.

US CDC Declares ByHeart Infant Botulism Outbreak Over, Probe Continues

The U.S. Centers for Disease Control and Prevention declared the multistate infant botulism outbreak linked ⁠to ByHeart powdered infant formula over on Thursday, while...

Todays Updates

Biomarker Flags 10-Fold Recurrence Risk in Testicular Cancer

MiR-371 isn’t ready for the clinic yet, but it is ready for interventional trials to see if it can refine adjuvant chemotherapy decisions in stage I testicular cancer.

FDA Approves New Drug Combo for RR Multiple Myeloma

Teclistamab plus daratumumab and hyaluronidase-fihj is approved for relapsed or refractory MM after one prior line of therapy, including a proteasome inhibitor and immunomodulatory agent.

Todays Updates

Biomarker Flags 10-Fold Recurrence Risk in Testicular Cancer

MiR-371 isn’t ready for the clinic yet, but it is ready for interventional trials to see if it can refine adjuvant chemotherapy decisions in stage I testicular cancer.

FDA Approves New Drug Combo for RR Multiple Myeloma

Teclistamab plus daratumumab and hyaluronidase-fihj is approved for relapsed or refractory MM after one prior line of therapy, including a proteasome inhibitor and immunomodulatory agent.

Latest News

Researchers report that photodynamic therapy increases antibiotic penetration and disrupts resistance mechanisms in laboratory strains.

An infectious intestinal disease episode can be noted in both primary care and hospital admissions, with children and older adults having higher odds of admissions during a primary care episode.

According to a study of more than 5.5 million adults aged 50 years or older, vaccination with the bivalent BA.1 mRNA booster lowers risks for COVID-related hospitalisation and death.

Older adults of Norwegian origin and those who are unmarried face an increased risk for humerus fractures, with a higher incidence seen in winter than in summer and more injuries occurring outdoors.

Twenty new DEXA scanners will expand NHS capacity in England, aiming to speed diagnosis and reduce fragility fractures.

The U.S. Centers for Disease Control and Prevention declared the multistate infant botulism outbreak linked ⁠to ByHeart powdered infant formula over on Thursday, while...

News All Time

US CDC Cancels February Vaccine Adviser Meeting; no New One Set Yet

A U.S. vaccine advisory committee meeting scheduled for later this month by the Centers for Disease Control and Prevention will not be held, with no ⁠new dates announced,...

Updates in Complicated UTI Classification and Treatment

Updates in Complicated UTI Classification and Treatment

Here Today, Safe Tomorrow: Accelerating HIV Prevention With Same-Day and Rapid PrEP Initiation

Here Today, Safe Tomorrow: Accelerating HIV Prevention With Same-Day and Rapid PrEP Initiation

Accelerating HIV Prevention in Primary Care Settings

Accelerating HIV Prevention in Primary Care Settings

Integrating Same-Day or Rapid PrEP Initiation With Substance Use Treatment to Support Holistic Harm Reduction

Integrating Same-Day or Rapid PrEP Initiation With Substance Use Treatment to Support Holistic Harm Reduction

Bringing Rapid PrEP to the Frontlines in Community Pharmacies

Bringing Rapid PrEP to the Frontlines in Community Pharmacies

My Child Was in an Active Shooter Lockdown. This Horror Will Come for Many of Us.

Here are lessons learned about a reality even physicians aren't trained for

Deaths Prompt Clinical Trial Hold; $8,000 'Scorpion' Bill; The Next COVID Vaccine

Health news and commentary gathered by MedPage Today staff

Doctors vs Advanced Practice Providers: A False Fault Line in Medicine

They are teammates working in a system that pits them against each other

Call 911 or Risk Losing the Baby? Raids Force Some Immigrants to Avoid Care.

Immigration sweeps add to the healthcare barriers that some already face

Coffee, Chocolate, and Cellular Aging; Medical Aircraft Crash Kills 5; AAP Sues HHS

Health news and commentary gathered by MedPage Today staff

Are We All as Miserable as the Doctors on 'The Pitt'?

Why some people choose careers that haunt them

After Judge's Ruling, HHS Can Resume Sharing Medicaid Data With Deportation Officers

But the decision strictly limits the scope of data that can be shared

Is Recovery-Oriented, Involuntary Psychiatric Treatment Possible?

A roadmap for responsible, ethical, and individualized intervention

DVT Assessment Strategy Safely Expands Rule-Out

Study validates age-adjusted D-dimer cutoff for ruling out leg deep vein thrombosis

Congressman Dies Suddenly; Doc Involved in Murder-Suicide; COVID Vaccine Makers Sued

Health news and commentary gathered by MedPage Today staff

Recommended News For You

Pancreatic Cancer: A Novel CD40 Agonist-Chemo Combo Shows Promise.

New tumor therapy approach reduces costs and side effects while increasing accessibility

Achieves a High Disease Control Rate in Head and Neck BCC with Vismodegib-RT Regimen.

Patients with metastatic breast cancer can predict their response to HER2-targeted therapy using whole-body PET/CT.

Avoiding Neuropathy From Chemo; Predictive Value of Screening EKGs

Frontline EGFR/VEGF Inhibition Slows Advanced EGFR-Positive Lung Cancer

For cancer patients who are not responding to chemotherapy, new genes and natural toxins offer hope.

Recommended Articles For You

Understanding Macrocytosis: Causes, Symptoms, and Treatment Options  

Unmasking the Subtle Symptoms of Colon Cancer 

Neoadjuvant Abraxane Chemotherapy Combined with Neutrophil Cytopharmaceuticals and Radiotherapy 

Revolutionizing Cancer Treatment: How Adoptive Cell Therapy is Overcoming Tumor Immune Evasion 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Including Isatuximab with a Standard Backbone Enhances Multiple Myeloma Results.

2.

Charting the Course: From Young Adult Leukemia Patient to Oncologist.

3.

Screening for prostate cancer: is it time to give up digital rectal examination?

4.

Too Many Kids With Sickle Cell Disease Aren't Getting Appropriate Preventive Care

5.

Charles III, King of Kings, is Cancerous.

1.

The Growing Crisis of Aplastic Anemia: A Call for Action

2.

The Silent Killer: Uncovering the Causes and Treatments of Hemorrhagic Gastritis

3.

Hemophilia Beyond Boundaries: Unconventional Therapies in Bleeding Disorder Care

4.

Unlocking the Potential of Immune Checkpoint Inhibitors: A Pioneering Case Series on the Role of Immunotherapy in Microsatellite-Instability-High Colorectal Cancer

5.

Understanding Adenomyosis: The Role of Ultrasound in Diagnosis Introduction

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion

2.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation

3.

Optimizing Treatment Options in Advanced Urothelial Carcinoma

4.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part V

5.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot